Latest Breaking News On - Andrewj barwicki - Page 1 : vimarsana.com

Anavex Life Sciences Announces Expansion of Leadership Team - Anavex Life Sciences (NASDAQ:AVXL)

NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of

Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference

Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update

Company to host a webcasttoday at 8:30 a.m. Eastern TimeNEW YORK, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the ...

Loop Media Reports 2024 Fiscal First Quarter Financial Results

Anavex Life Sciences To Announce Fiscal 2024 First Quarter Financial Results On Wednesday, February 7Th, 2024

Loop Media Schedules 2024 Fiscal First Quarter Conference Call for February 6, 2024 at 5:00 p.m. ET

Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in Humans

Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in Humans

NEW YORK, Jan. 24, 2024 -- Anavex Life Sciences Corp. , a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and...

Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia